Alzheimer's Disease

Showing NaN - NaN of 77

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in Worldwide (Lanabecestat)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +132 more
Nov 19, 2019

Alzheimer's Disease Trial in Canada, United States (ELND005 (scyllo-inositol))

Completed
  • Alzheimer's Disease
  • ELND005 (scyllo-inositol)
  • Phoenix, Arizona
  • +37 more
Oct 17, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +192 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +197 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +146 more
Sep 25, 2019

Alzheimer's Disease Trial in Canada, United States (AZD0530 100mg daily, AZD0530 125mg daily, Placebo)

Completed
  • Alzheimer's Disease
  • AZD0530 100mg daily
  • +2 more
  • Phoenix, Arizona
  • +21 more
Jul 25, 2019

Alzheimer's Disease Trial in New Haven (123-I MNI-340)

Terminated
  • Alzheimer's Disease
  • 123-I MNI-340
  • New Haven, Connecticut
    The Institute for Neurodegenerative Disorders
Apr 1, 2019

Alzheimer's Disease Trial in New Haven (I-123-MNI-168, 123-I MNI-168)

Terminated
  • Alzheimer's Disease
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Apr 1, 2019

Alzheimer's Disease Trial in New Haven (I123MNI388/I123MNI390)

Terminated
  • Alzheimer's Disease
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Apr 1, 2019

Alzheimer's Disease Trial in United States (T-817MA-H, T-817MA-L, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +49 more
Feb 12, 2019

Alzheimer's Disease Trial in United States (PF-04494700, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +61 more
Nov 28, 2018

Alzheimer's Disease, Huntington's Disease Trial in New Haven (Warfarin, Dimebon)

Completed
  • Alzheimer's Disease
  • Huntington's Disease
  • New Haven, Connecticut
    Pfizer Investigational Site
Oct 11, 2018

Alzheimer's Disease Trial in Worldwide (LY2886721, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +33 more
May 16, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 150 mg/day, TRx0237 250 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 150 mg/day
  • +2 more
  • Phoenix, Arizona
  • +120 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 200 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 200 mg/day
  • Placebo
  • Phoenix, Arizona
  • +94 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)

Completed
  • Alzheimer's Disease
  • Rosiglitazone Extended Release 2mg
  • +3 more
  • Litchfield Park, Arizona
  • +248 more
Oct 23, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone XR)

Terminated
  • Alzheimer's Disease
  • Rosiglitazone XR
  • Litchfield Park, Arizona
  • +271 more
Oct 11, 2017

Alzheimer's Disease Trial in Worldwide (MABT5102A, )

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +91 more
Jul 10, 2017

Alzheimer's Disease Trial in Worldwide (RO4602522, Placebo, Donepezil)

Completed
  • Alzheimer's Disease
  • Anaheim, California
  • +141 more
May 25, 2017

Alzheimer's Disease Trial in Worldwide (PF-05212377 (SAM-760), Placebo)

Terminated
  • Alzheimer's Disease
  • PF-05212377 (SAM-760)
  • Placebo
  • Costa Mesa, California
  • +59 more
Jan 30, 2017

Alzheimer's Disease Trial in New Haven ([123I]MNI-672 SPECT)

Completed
  • Alzheimer's Disease
  • [123I]MNI-672 SPECT
  • New Haven, Connecticut
    Molecular NeuroImaging, LLC
Dec 15, 2016

Alzheimer's Disease Trial in United States (Dimebon, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +27 more
Sep 24, 2016

Alzheimer's Disease Trial in Worldwide (Dimebon, Placebo comparator)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +100 more
Sep 24, 2016

Alzheimer's Disease Trial in United States (Resveratrol, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +25 more
May 6, 2016

Alzheimer's Disease, Dementia Trial in Worldwide (EVP-6124)

Terminated
  • Alzheimer's Disease
  • Dementia
  • Phoenix, Arizona
  • +85 more
May 2, 2016